Skip to main content

Significant Pharmaceuticals Reported In Us Patents

In Order to Read Online or Download Significant Pharmaceuticals Reported In Us Patents Full eBooks in PDF, EPUB, Tuebl and Mobi you need to create a Free account. Get any books you like and read everywhere you want. Fast Download Speed ~ Commercial & Ad Free. We cannot guarantee that every book is in the library!

Significant Pharmaceuticals Reported in US Patents

Significant Pharmaceuticals Reported in US Patents Book
Author : Thomas F. DeRosa
Publisher : Elsevier
Release : 2010-07-07
ISBN : 9780080480916
Language : En, Es, Fr & De

GET BOOK

Book Description :

Significant Pharmaceuticals Reported in US Patents identifies the next generation of pharmaceuticals reported in US Patents. This "hands-on" title provides explicit laboratory methods for preparing the most recent and effective medications. Each entry documents the biological testing protocols used to evaluate a drug and the significance of the current treatment agent over previous methods. Pharmaceuticals are included in this review only if at least two of the following criteria were met: Effectiveness in treating an illness, Innovative, ease of preparation, synergy with existing Medications. Pharmaceuticals are reported for 27 separate classes of illness, including: AIDS, Alzheimer's Disease, Cardiovascular Disorders, Diabetes, Epilepsy, Hepatitis C, Osteoporosis, Obesity and Sleep Disorders. Significant Pharmaceuticals Reported in US Patents has been designed to be used as both a reference and synthetic guide for pharmaceutical, medicinal and organic chemists and graduate students. Researchers working in other areas will also find the information valuable as in many instances intermediates or the next generation pharmaceutical are readily convertible into other industrial products including: anti-oxidants, chemical additives, herbicides, polymer precursors, water purification agents. Clear structural depictions of reagents and chemical transformations have been supplied to permit the identification of other future applications. Identifies next generation pharmaceuticals Provides practical preparation methods for each active agent and derivatives Documents the analytical characterization and biological testing results of active agents

Advances in Synthetic Organic Chemistry and Methods Reported in US Patents

Advances in Synthetic Organic Chemistry and Methods Reported in US Patents Book
Author : Thomas F. DeRosa
Publisher : Elsevier
Release : 2006-03-21
ISBN : 9780080455631
Language : En, Es, Fr & De

GET BOOK

Book Description :

Advances in Synthetic Organic Chemistry and Methods Reported in US Patents provides synthetic guidelines for preparing current and commercially significant organic compounds, derivatives, and intermediates as reported in issued US Patents. Industries surveyed include agrochemical, cosmetics and personal care products. Each entry contains extensive information such as explicit laboratory directions for preparing all chemical intermediates and characterization data. Furthermore, product optimization studies, industrial preparation, and new synthetic methods have been included for selected entries, as well as projected research directions for future product development. In Advances in Synthetic Organic Chemistry and Methods Reported in US Patents the author's practical approach enables readers to identify research and market trends, and stay up-to-date on current developments in the field. Provides synthetic guidelines for preparing current and commercially significant organic compounds, derivatives, and intermediates as reported in issued US Patents Identifies product development trends to help determine research areas Elucidates use of the US Patent and Trademark Office database

Advances in Polymer Chemistry and Methods Reported in Recent US Patents

Advances in Polymer Chemistry and Methods Reported in Recent US Patents Book
Author : Thomas F. DeRosa
Publisher : John Wiley & Sons
Release : 2008-09-16
ISBN : 0470385987
Language : En, Es, Fr & De

GET BOOK

Book Description :

The objective of this book is to convey to academic and industrial researchers and students advances in synthetic and characterization methods in 9 selected areas of polymer chemistry reported in 2007-2008 US Patents. It reviews the impact of newer bulk anionic, cationic, and free radical polymerization methods within selected industrial applications. Bulk and surface crosslinking agents using selected bi- and tri-functional reagents, photochemical methods, or free radical agents are also reviewed. Finally, there is a separate section on cationic and cationic ring opening polymerization reactions describing di- and tri-heterocyclic monomers and their use in medical devices.

Next Generation of International Chemical Additives

Next Generation of International Chemical Additives Book
Author : Thomas F. DeRosa
Publisher : Elsevier
Release : 2012
ISBN : 0444537880
Language : En, Es, Fr & De

GET BOOK

Book Description :

This book identifies the next generation chemical additives for eight selected industries. The text also provides methods for their preparation, additive treatment levels, and testing methods to evaluate additive performance.--

The Political Economy of Pharmaceutical Patents

The Political Economy of Pharmaceutical Patents Book
Author : Sherry S. Marcellin
Publisher : Ashgate Publishing, Ltd.
Release : 2010
ISBN : 9781409412144
Language : En, Es, Fr & De

GET BOOK

Book Description :

A fresh, multidisciplinary and exciting look at the making and remaking of pharmaceutical patents at the GAT/WTO, utilizing a Coxian political economy of continuity and change in the global political economy (GPE). Marcellin addresses the role of the transnational drug industry in the making of the patent provisions in the original TRIPS Agreement, and consequently the role of the African Group at the WTO in the remaking of patent provisions.

Patent Settlements in the Pharmaceutical Industry under US Antitrust and EU Competition Law

Patent Settlements in the Pharmaceutical Industry under US Antitrust and EU Competition Law Book
Author : Amalia Athanasiadou
Publisher : Kluwer Law International B.V.
Release : 2018-08-14
ISBN : 9403501146
Language : En, Es, Fr & De

GET BOOK

Book Description :

Reverse payment settlements or “pay-for-delay agreements” between originators and generic drug manufacturers create heated debates regarding the balance between competition and intellectual property law. These settlements touch upon sensitive issues such as timely generic entry and access to affordable pharmaceuticals and also the need to preserve innovation incentives for originators and to strengthen the pipeline of life-saving pharmaceuticals. This book is one of the first to critically and comparatively analyse how such patent settlements and various other strategies employed by the pharmaceutical industry are scrutinised by both United States (US) and European courts and enforcement authorities, and to discuss the applicable legal tests and the main criteria used for their assessment. The book’s ultimate objective is to provide guidance to the pharmaceutical industry regarding the types of patent settlements, strategies and conduct which may be problematic from US antitrust and European Union (EU) competition law perspectives and to assist practitioners in structuring settlements which are both efficient and compliant. To this end, an exhaustive legal analysis of some of the most controversial issues regarding pharmaceutical patent settlements is provided, including: – the lengthy split among US Circuit Courts on the issue of pay-for-delay settlements, its resolution by the US Supreme Court in FTC v. Actavisand subsequent jurisprudence; – the decision of Lundbeck v. Commissionby the European General Court and the Servier decision of the European Commission; – the Roche/Novartisdecision of the European Court of Justice and the most important decisions by National Competition Authorities on pharma patent settlements in the EU; – an overview of other types of strategies such as product-hopping and product reformulations, no-authorised generic commitments, problematic side-deals, mechanisms affecting generic substitution; – the rejection of the “scope of the patent” test in both the US and the EU and the balancing of patent law and antitrust law considerations in the prevailing applicable tests; – the benefits of settlements and the main criteria for assessing their legitimacy under US antitrust and EU competition law. The analysis provides concrete examples of both illegitimate and legitimate settlements and strategies, emphasising on conduct that falls within a grey zone and on the circumstances and criteria under which such conduct could be deemed problematic from an antitrust perspective. This book will serve as a valuable guide for pharmaceutical companies wishing to minimise the risk of engaging in conduct that could potentially infringe US antitrust and EU competition law. It further aims to save courts and enforcement agencies and also practitioners and academics considerable time and resources by providing an exhaustive analysis of the relevant caselaw, with the ultimate goal to increase legal certainty on the most controversial aspects of patent settlements in the pharmaceutical industry.

Pharmaceutical and Biotech Patent Law

Pharmaceutical and Biotech Patent Law Book
Author : David K. Barr,Daniel Louis Reisner
Publisher : Unknown
Release : 2010
ISBN : 0987650XXX
Language : En, Es, Fr & De

GET BOOK

Book Description :

Download Pharmaceutical and Biotech Patent Law book written by David K. Barr,Daniel Louis Reisner, available in PDF, EPUB, and Kindle, or read full book online anywhere and anytime. Compatible with any devices.

Patents and Pharmaceutical Drugs

Patents and Pharmaceutical Drugs Book
Author : Julio J. Nogués
Publisher : World Bank Publications
Release : 1990
ISBN : 0987650XXX
Language : En, Es, Fr & De

GET BOOK

Book Description :

Download Patents and Pharmaceutical Drugs book written by Julio J. Nogués, available in PDF, EPUB, and Kindle, or read full book online anywhere and anytime. Compatible with any devices.

United States Congressional Serial Set

United States Congressional Serial Set Book
Author : Anonim
Publisher : Unknown
Release : 1984
ISBN : 0987650XXX
Language : En, Es, Fr & De

GET BOOK

Book Description :

Download United States Congressional Serial Set book written by , available in PDF, EPUB, and Kindle, or read full book online anywhere and anytime. Compatible with any devices.

Patents in the Knowledge Based Economy

Patents in the Knowledge Based Economy Book
Author : National Research Council,Policy and Global Affairs,Board on Science, Technology, and Economic Policy,Committee on Intellectual Property Rights in the Knowledge-Based Economy
Publisher : National Academies Press
Release : 2003-08-11
ISBN : 9780309167185
Language : En, Es, Fr & De

GET BOOK

Book Description :

This volume assembles papers commissioned by the National Research Council’s Board on Science, Technology, and Economic Policy (STEP) to inform judgments about the significant institutional and policy changes in the patent system made over the past two decades. The chapters fall into three areas. The first four chapters consider the determinants and effects of changes in patent “quality.†Quality refers to whether patents issued by the U.S. Patent and Trademark Office (USPTO) meet the statutory standards of patentability, including novelty, nonobviousness, and utility. The fifth and sixth chapters consider the growth in patent litigation, which may itself be a function of changes in the quality of contested patents. The final three chapters explore controversies associated with the extension of patents into new domains of technology, including biomedicine, software, and business methods.

Daily Labor Report

Daily Labor Report Book
Author : Anonim
Publisher : Unknown
Release : 1996-05
ISBN : 0987650XXX
Language : En, Es, Fr & De

GET BOOK

Book Description :

Download Daily Labor Report book written by , available in PDF, EPUB, and Kindle, or read full book online anywhere and anytime. Compatible with any devices.

PAREXEL s Pharmaceutical R D Statistical Sourcebook

PAREXEL s Pharmaceutical R   D Statistical Sourcebook Book
Author : Anonim
Publisher : Unknown
Release : 2002
ISBN : 0987650XXX
Language : En, Es, Fr & De

GET BOOK

Book Description :

Download PAREXEL s Pharmaceutical R D Statistical Sourcebook book written by , available in PDF, EPUB, and Kindle, or read full book online anywhere and anytime. Compatible with any devices.

The Chemist s Companion Guide to Patent Law

The Chemist s Companion Guide to Patent Law Book
Author : Chris P. Miller,Mark J. Evans
Publisher : John Wiley & Sons
Release : 2011-03-01
ISBN : 9781118035191
Language : En, Es, Fr & De

GET BOOK

Book Description :

Written by an individual with experience as both a chemist and a patent attorney, The Chemist's Companion Guide to Patent Law covers everything the student or working chemist needs to know about patentability, explaining important concepts of patent law (such as novelty, non-obviousness, and freedom-to-operate) in easy-to-understand terms. Through abundant examples from case law as well as real-world situations with which a researcher might be faced, this book provides readers with a better understanding of how to put that knowledge into practice.

Official Gazette of the United States Patent and Trademark Office

Official Gazette of the United States Patent and Trademark Office Book
Author : Anonim
Publisher : Unknown
Release : 1996
ISBN : 0987650XXX
Language : En, Es, Fr & De

GET BOOK

Book Description :

Download Official Gazette of the United States Patent and Trademark Office book written by , available in PDF, EPUB, and Kindle, or read full book online anywhere and anytime. Compatible with any devices.

Drug Prices

Drug Prices Book
Author : Kevin J Hickey,Kevin T Richards,Erin H Ward
Publisher : Independently Published
Release : 2021-03-03
ISBN : 0987650XXX
Language : En, Es, Fr & De

GET BOOK

Book Description :

Intellectual property (IP) rights play an important role in the development and pricing of prescription drugs and biologics. To encourage innovation, IP law grants inventors exclusive rights in a particular invention or product, potentially enabling them to charge higher-thancompetitive prices. IP rights are typically justified as necessary to allow pharmaceutical manufacturers the ability to recoup substantial costs in research and development, including clinical trials and other tests necessary to obtain regulatory approval from the U.S. Food and Drug Administration (FDA). However, IP rights have been criticized as contributing to high prices for pharmaceutical products in the United States by operating to deter or delay competitionfrom generic drug and biosimilar manufacturers.Two main types of IP rights may protect pharmaceutical products: patents and regulatory exclusivities. Patents, which are available for a wide range of technologies beyond pharmaceuticals, are granted by the U.S. Patent and Trademark Office. Patents may claim chemical compounds in the pharmaceutical product, a method of using the product, a method of making or administering the product, or a variety of other patentable inventions relating to a drug or biologic. The holder of a valid patent generally has the exclusive right to make, use, sell, and import the invention for a term lasting approximately 20 years. Pharmaceutical patent disputes are subject to certain specialized procedures under the Hatch-Waxman Act and the Biologics Price Competition and Innovation Act, which can affect when generic and biosimilar manufacturers can market their follow-on products.In addition to patent protection, certain pharmaceuticals, such as innovative products or those that serve particular needs, may qualify for periods of regulatory exclusivity when they are approved or licensed by FDA. Pharmaceutical products may only be sold in the United States after FDA has determined they are safe and effective, based on submitted data, and has approved or licensed them. FDA generally may not accept and/or approve a generic drug or biosimilar if the pharmaceutical product being used as a reference to show the follow-on product is safe and effective is covered by an unexpired regulatoryexclusivity. Regulatory exclusivities vary in length from six months to 12 years, depending on the basis for the exclusivity.In recent years, some Members of Congress have introduced bills to address these and other IP-related issues that someperceive as contributing to high pharmaceutical prices.

The United States patents quarterly Annual Digest

The United States patents quarterly  Annual Digest Book
Author : Anonim
Publisher : Unknown
Release : 2004
ISBN : 0987650XXX
Language : En, Es, Fr & De

GET BOOK

Book Description :

Download The United States patents quarterly Annual Digest book written by , available in PDF, EPUB, and Kindle, or read full book online anywhere and anytime. Compatible with any devices.

Reports of Patent Design and Trade Mark Cases

Reports of Patent  Design  and Trade Mark Cases Book
Author : Anonim
Publisher : Unknown
Release : 1971
ISBN : 0987650XXX
Language : En, Es, Fr & De

GET BOOK

Book Description :

Download Reports of Patent Design and Trade Mark Cases book written by , available in PDF, EPUB, and Kindle, or read full book online anywhere and anytime. Compatible with any devices.

Government Patent Policy Study

Government Patent Policy Study Book
Author : Harbridge House, inc
Publisher : Unknown
Release : 1968
ISBN : 0987650XXX
Language : En, Es, Fr & De

GET BOOK

Book Description :

Download Government Patent Policy Study book written by Harbridge House, inc, available in PDF, EPUB, and Kindle, or read full book online anywhere and anytime. Compatible with any devices.

Government Patent Policy Study

Government Patent Policy Study Book
Author : Federal Council for Science and Technology (U.S.). Committee on Government Patent Policy,Harbridge House, inc
Publisher : Unknown
Release : 1968
ISBN : 0987650XXX
Language : En, Es, Fr & De

GET BOOK

Book Description :

Download Government Patent Policy Study book written by Federal Council for Science and Technology (U.S.). Committee on Government Patent Policy,Harbridge House, inc, available in PDF, EPUB, and Kindle, or read full book online anywhere and anytime. Compatible with any devices.

Propanolamines Advances in Research and Application 2013 Edition

Propanolamines   Advances in Research and Application  2013 Edition Book
Author : Anonim
Publisher : ScholarlyEditions
Release : 2013-05-01
ISBN : 1490103953
Language : En, Es, Fr & De

GET BOOK

Book Description :

Propanolamines—Advances in Research and Application: 2013 Edition is a ScholarlyEditions™ book that delivers timely, authoritative, and comprehensive information about Bisoprolol. The editors have built Propanolamines—Advances in Research and Application: 2013 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about Bisoprolol in this book to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of Propanolamines—Advances in Research and Application: 2013 Edition has been produced by the world’s leading scientists, engineers, analysts, research institutions, and companies. All of the content is from peer-reviewed sources, and all of it is written, assembled, and edited by the editors at ScholarlyEditions™ and available exclusively from us. You now have a source you can cite with authority, confidence, and credibility. More information is available at http://www.ScholarlyEditions.com/.